Log in

Relevant bibliographies by topics / Direct-to-Consumer Advertising (DTC) / Journal articles

To see the other types of publications on this topic, follow the link: Direct-to-Consumer Advertising (DTC).

Journal articles on the topic 'Direct-to-Consumer Advertising (DTC)'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Direct-to-Consumer Advertising (DTC).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Coney, Sandra. "Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New Zealand." Journal of Public Policy & Marketing 21, no. 2 (2002): 213–23. http://dx.doi.org/10.1509/jppm.21.2.213.17592.

Full text

Abstract:

New Zealand is one of only two countries in the world that allows direct-to-consumer (DTC) advertising. Such advertising has increased dramatically since the mid-1990s, and a wide range of promotional activities currently takes place. Compliance with the legislation occurs through an industry body that hears complaints over alleged breaches. The weakness of the organized consumer sector in the country means there is a paucity of complaints, yet a self-regulating system is reliant on complaints for compliance. The author describes the unsatisfactory experience of taking a complaint and examines

APA, Harvard, Vancouver, ISO, and other styles

2

Wyke, Alexandra. "Direct-to-consumer (DTC) Marketing — Patient views: DTC advertising." Journal of Medical Marketing 4, no. 4 (2004): 310–12. http://dx.doi.org/10.1057/palgrave.jmm.5040179.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Atul, Bhole* Alisha Dhandore Anushka Chormale Sachin Navale Dr. Nilesh Chougule. "Assessing The Effects of Dtc Advertising on The Pharmaceutical Market." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 152–65. https://doi.org/10.5281/zenodo.14259870.

Full text

Abstract:

The landscape of pharmaceutical marketing has evolved significantly with the emergence of Direct-to-Consumer (DTC) advertising, fundamentally reshaping the relationship between pharmaceutical companies, healthcare providers, and patients. This review article explores the multifaceted impact of DTC advertising on pharmaceutical sales and the broader healthcare ecosystem. Initially, pharmaceutical marketing primarily targeted healthcare professionals through detailing, but regulatory changes in the 1990s, particularly in the U.S., enabled direct engagement with consumers via mass media and digit

APA, Harvard, Vancouver, ISO, and other styles

4

Muthaly, Siva, Hong-Youl Ha, Jing Ping Yeo, and Nam-Yun Kim. "Effects on Direct-to-Consumer Advertising of Prescription Drugs in Singapore: The Moderating Role of Low Credibility." International Area Review 12, no. 2 (2009): 215–29. http://dx.doi.org/10.1177/223386590901200211.

Full text

Abstract:

As consumer beliefs about direct-to-consumer (“DTC‘) advertising vary, two different types of beliefs (beliefs about DTC advertising and beliefs about quality of treatment) are associated with how consumers' beliefs affect behavioral intentions. The authors also consider how consumers' judgments of DTC advertising of prescription drugs vary with different levels of credibility. Taking a moderating effect perspective on the consumer beliefs-behavioral intentions formation, the authors theorize that the lower level of credibility is a key element in facilitating consumer activity. Data from Sing

APA, Harvard, Vancouver, ISO, and other styles

5

Calfee, John E. "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs." Journal of Public Policy & Marketing 21, no. 2 (2002): 174–93. http://dx.doi.org/10.1509/jppm.21.2.174.17580.

Full text

Abstract:

In August 1997, the Food and Drug Administration (FDA) announced a reinterpretation of its rules on direct-to-consumer (DTC) advertising, the effect of which was to permit branded broadcast advertisements and therefore to increase the volume of DTC advertising several-fold. A substantial body of research, consisting primarily of consumer surveys, provides the basis for a preliminary assessment of the effects of DTC advertisements. The FDA's own assessment, that DTC advertisements can provide substantial benefits and do not appear to cause substantial harm, is consistent with survey and other d

APA, Harvard, Vancouver, ISO, and other styles

6

Limbu, Yam, and Ivonne M. Torres. "The Effects of Involvement and Ad Type on Attitudes toward Direct-To-Consumer Advertising of Prescription Drugs." Journal of Health and Human Services Administration 32, no. 1 (2009): 51–82. http://dx.doi.org/10.1177/107937390903200102.

Full text

Abstract:

This article examines consumers’ attitudes toward Direct-to-Consumer (DTC) advertising of prescription drugs that are influenced by the use different types of DTC ads and product involvement. Our findings suggest that product involvement and the type of DTC ad are significant predictors of consumers’ attitudinal responses toward DTC advertising. High involvement consumers have more favorable attitudes toward the drug's price, DTC ad and brand name, and a higher intention to ask a doctor about the advertised drug than low involvement consumers. In contrast to Informational and Reminder DTC ads,

APA, Harvard, Vancouver, ISO, and other styles

7

Sheehan, Kim Bartel. "Focus on Research: Direct-to-Consumer (DTC) Advertising: Introduction." Journal of Advertising 36, no. 3 (2007): 121. http://dx.doi.org/10.2753/joa0091-3367360309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Constantin, Dan Alexandru, Ionut Horia Cioriceanu, and Liliana Marcela Rogozea. "Ethical Guidelines for Direct-To-Consumer Promotion of Transcranial Magnetic Stimulation." American Journal of Therapeutics 32, no. 3 (2025): e269-e273. https://doi.org/10.1097/mjt.0000000000001974.

Full text

Abstract:

Background: Medical providers started to consider Transcranial Magnetic Stimulation (TMS) for the noninvasive treatment of different psychiatric and neurology disorders as this technique become more popular in recent years. Many medical providers are trying to reach patients using direct-to-consumer (DTC) promotion of approved and off-label indications. Most of the time, these ads exaggerate benefits, create unrealistic expectations, and often exaggerate benefits. The procedure is expensive, and many insurance companies do not reimburse it; some patients may not have access to it. The study ex

APA, Harvard, Vancouver, ISO, and other styles

9

Cheong, Yunjae, and Kihan Kim. "An assessment of direct-to-consumer (DTC) pharmaceutical advertising spending." International Journal of Advertising 33, no. 1 (2014): 91–112. http://dx.doi.org/10.2501/ija-33-1-091-112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Vigilante, William J., Christopher Mayhorn, and Michael S. Wogalter. "Direct-to-Consumer (DTC) Prescription Drug Advertising on Television and Online Purchases of Medications." Proceedings of the Human Factors and Ergonomics Society Annual Meeting 51, no. 18 (2007): 1272–76. http://dx.doi.org/10.1177/154193120705101847.

Full text

Abstract:

The present research explored several aspects concerning hazard/risk communication in direct-to-consumer (DTC) television advertising. Results indicated that participants frequently encounter DTC ads and some report information seeking as a result. Participants reported that their physicians will fill their requests for DTC advertised drugs. They report infrequently making online (Internet) purchases of prescription drugs possibly due to safety and legal concerns. Implications of the findings for factors/ergonomics (HF/E) professionals are discussed.

APA, Harvard, Vancouver, ISO, and other styles

11

Murray, Michael. "Direct-to-Consumer Prescription Drug Advertising in a Global Context: A Comparison between New Zealand and the United States." SALUTE E SOCIETÀ, no. 2 (July 2009): 189–207. http://dx.doi.org/10.3280/ses2009-en2013.

Full text

Abstract:

- The pharmaceutical industry is a transnational industry with a global influence and interests in expanding their markets to include as much of the world's population as possible. Direct-to-consumer (DTC) prescription drug advertising is a potential tool for the global spread of industry conceptions of health and illness, and can be seen as both a cause and a result of globalization. Among developed countries, DTC advertising is currently only legal in New Zealand and the United States, but debates are taking place worldwide as the pharmaceutical industry uses its global influence to lobby fo

APA, Harvard, Vancouver, ISO, and other styles

12

Beltramini, Richard F. "Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs." Journal of Business Ethics 63, no. 4 (2006): 333–43. http://dx.doi.org/10.1007/s10551-005-4711-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Nagappan, Ashwini, Louiza Kalokairinou, and Anna Wexler. "Ethical issues in direct-to-consumer healthcare: A scoping review." PLOS Digital Health 3, no. 2 (2024): e0000452. http://dx.doi.org/10.1371/journal.pdig.0000452.

Full text

Abstract:

An increasing number of health products and services are being offered on a direct-to-consumer (DTC) basis. To date, however, scholarship on DTC healthcare products and services has largely proceeded in a domain-specific fashion, with discussions of relevant ethical challenges occurring within specific medical specialties. The present study therefore aimed to provide a scoping review of ethical issues raised in the academic literature across types of DTC healthcare products and services. A systematic search for relevant publications between 2011–2021 was conducted on PubMed and Google Scholar

APA, Harvard, Vancouver, ISO, and other styles

14

Rudge, Chris, Narcyz Ghinea, Megan Munsie, and Cameron Stewart. "Regulating autologous stem cell interventions in Australia: updated review of the direct-to-consumer advertising restrictions." Australian Health Review 45, no. 4 (2021): 507. http://dx.doi.org/10.1071/ah20217.

Full text

Abstract:

ObjectiveThis paper provides an update and overview of the law governing direct-to-consumer (DTC) advertising of autologous stem cell interventions (ASCIs) in Australia. It follows significant changes to the advertising regulations made in 2018. MethodsThe paper reviews the three primary sources or ‘centres’ of law regulating ASCIs in Australia, together with the relevant guidance documents that supplement these sources. It provides analysis of how the post-2018 advertising regulations, contained in the Therapeutic Goods Act 1989 (Cwlth), apply to all ‘biologicals’, including ASCIs. It demonst

APA, Harvard, Vancouver, ISO, and other styles

15

Lurie, Peter. "DTC Advertising Harms Patients and Should Be Tightly Regulated." Journal of Law, Medicine & Ethics 37, no. 3 (2009): 444–50. http://dx.doi.org/10.1111/j.1748-720x.2009.00405.x.

Full text

Abstract:

Like all interventions in health care, direct-to-consumer (DTC) advertising should be evaluated by comparing its risks to its benefits, in the context of the available or potentially available alternatives. The objective, of course, is to realize any unique benefits while minimizing the risks. On balance, the adverse effects of DTC advertising outweigh the still-undemonstrated benefits of the advertising.DTC advertising must be seen in the context of overall pharmaceutical company expenditures on advertising. In 2005, the industry spent $29.9 billion dollars on promotions (up from $11.4 billio

APA, Harvard, Vancouver, ISO, and other styles

16

Spector-Bagdady, Kayte. "Reconceptualizing Consent for Direct-to-Consumer Health Services." American Journal of Law & Medicine 41, no. 4 (2015): 568–616. http://dx.doi.org/10.1177/0098858815622191.

Full text

Abstract:

The market for direct-to-consumer (DTC) health services continues to grow rapidly with former patients converting to customers for the opportunity to purchase varied diagnostic tests without the involvement of their clinician. For the first time a DTC genetic testing company is advertising health-related reports “that meet [Food and Drug Administration] standards for being clinically and scientifically valid.” Ethicists and regulatory agencies alike have recognized the need for a more informed transaction in the DTC context, but how should we classify a commercial transaction for something nor

APA, Harvard, Vancouver, ISO, and other styles

17

Handlin, Amy, Joseph B. Mosca, Dana A. Forgione, and Dennis Pitta. "DTC pharmaceutical advertising: the debate’s not over." Journal of Consumer Marketing 20, no. 3 (2003): 227–37. http://dx.doi.org/10.1108/07363760310472254.

Full text

Abstract:

Direct‐to‐consumer (DTC) advertising of prescription drugs is no longer the novel experiment it was during the late 1980s. Liberalization of the Food and Drug Administration regulations in the USA, combined with a substantial body of evidence that DTC advertising is a stimulus to consumer purchasing behavior, has resulted in DTC advertising becoming a standard component of every major drug company’s marketing plan. Research since the late 1980s has compared consumers’ perceptions of DTC ads with the perceptions of physicians. While the studies are methodologically diverse, the results have bee

APA, Harvard, Vancouver, ISO, and other styles

18

Goldberg, Scott. "Advertising to the End Consumers by Pharmaceutical Companies." International Journal of Research in Business and Social Science (2147-4478) 2, no. 4 (2013): 60–71. http://dx.doi.org/10.20525/ijrbs.v2i4.81.

Full text

Abstract:

   The last several years have seen an increase in the number of direct to consumer advertisements by pharmaceutical companies. Direct to Consumer advertisements (DTC) means targeting the end consumer through advertisements on television, radio, in newspapers, magazines, and the Internet. The qualitative study presents data and supports the need for a future quantitative study to ask physicians and consumers their opinions on whether pharmaceutical companies should be allowed to advertise directly to the end consumer. This article reviews the literature on this controversial

APA, Harvard, Vancouver, ISO, and other styles

19

Eichner, Riva, and Thomas J. Maronick. "A Review of Direct-to-Consumer (DTC) Advertising and Sales of Prescription Drugs: Does DTC Advertising Increase Sales and Market Share?" Journal of Pharmaceutical Marketing & Management 13, no. 4 (2001): 19–42. http://dx.doi.org/10.3109/j058v13n04_02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tipton, David. "A Review of Direct-to-Consumer (DTC) Advertising and Sales of Prescription Drugs:." Journal of Pharmaceutical Marketing & Management 13, no. 4 (2001): 19–43. http://dx.doi.org/10.1300/j058v13n04_02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lee, Byoungkwan, Charles T. Salmon, and Hye-Jin Paek. "The Effects Of Information Sources On Consumer Reactions To Direct-to-Consumer (DTC) Prescription Drug Advertising: A Consumer Socialization Approach." Journal of Advertising 36, no. 1 (2007): 107–19. http://dx.doi.org/10.2753/joa0091-3367360108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Huh, Jisu, and Wonsun Shin. "Consumer responses to pharmaceutical-company-sponsored disease information websites and DTC branded websites." International Journal of Pharmaceutical and Healthcare Marketing 9, no. 4 (2015): 306–29. http://dx.doi.org/10.1108/ijphm-05-2014-0026.

Full text

Abstract:

Purpose – This study aims to investigate pharmaceutical company-sponsored disease information websites that are created and operated by pharmaceutical companies. Without clear indication of the site ownership, these websites look like non-advertising health information websites. Consumers’ responses to pharmaceutical company-sponsored disease information websites were examined in comparison to their responses to typical direct-to-consumer (DTC) drug brand websites. Design/methodology/approach – A field experiment was conducted with a representative sample of US adults. Study subjects were rand

APA, Harvard, Vancouver, ISO, and other styles

23

Boudewyns, Vanessa, and Pamela A. Williams. "Content analysis of comparative claims in drug advertisements." International Journal of Pharmaceutical and Healthcare Marketing 10, no. 3 (2016): 302–22. http://dx.doi.org/10.1108/ijphm-09-2014-0055.

Full text

Abstract:

Purpose The purpose of this study is to describe the trends and practices of comparative prescription drug advertising by examining the types of comparative claims made in direct-to-consumer (DTC) and direct-to-physician (DTP) print advertisements. Design/methodology/approach The authors conducted a content analysis of 54 DTC and DTP print prescription drug advertisements (published between 1997 and 2014) with comparative claims. Findings Efficacy-based comparisons appeared in 64 per cent of advertisements, and attribute-based comparisons appeared in 37 per cent of advertisements. Most adverti

APA, Harvard, Vancouver, ISO, and other styles

24

Rollins, Brent, and Nilesh Bhutada. "Impact of celebrity endorsements in disease-specific direct-to-consumer (DTC) advertisements." International Journal of Pharmaceutical and Healthcare Marketing 8, no. 2 (2014): 164–77. http://dx.doi.org/10.1108/ijphm-05-2013-0024.

Full text

Abstract:

Purpose – The purpose of this paper is to analyze the effects on consumer response between disease-specific advertising containing a celebrity compared to a non-celebrity endorser. Design/methodology/approach – A randomized, cross-sectional two (endorser type) by two (levels of disease state involvement) factorial design was used. Respondents (over the age of 18) were randomly shown one of the ad types and then responded to an online survey questionnaire containing questions and various scales measuring disease state involvement, endorser credibility, attitude toward the ad and company, attent

APA, Harvard, Vancouver, ISO, and other styles

25

Jung, Wan S., Eun Soo Rhee, and Jihye Kim. "The influence of message framing and message familiarity on direct-to-consumer (DTC) antidepressant advertising." Journal of Communication in Healthcare 5, no. 1 (2012): 23–31. http://dx.doi.org/10.1179/1753807611y.0000000019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Huh, Jisu, and Rita Langteau. "Presumed Influence of Direct-to-Consumer (DTC) Prescription Drug Advertising on Patients: The Physician's Perspective." Journal of Advertising 36, no. 3 (2007): 151–72. http://dx.doi.org/10.2753/joa0091-3367360312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Murray, Joshua. "La pubblicitÀ per i farmaci con obbligo di prescrizione in un contesto globale: un confronto tra la Nuova Zelanda e gli Stati Uniti." SALUTE E SOCIETÀ, no. 2 (July 2009): 202–21. http://dx.doi.org/10.3280/ses2009-002013.

Full text

Abstract:

- The pharmaceutical industry is a transnational industry with a global influence and interests in expanding their markets to include as much of the world's population as possible. Direct-to-consumer (DTC) prescription drug advertising is a potential tool for the global spread of industry conceptions of health and illness, and can be seen as both a cause and a result of globalization. Among developed countries, DTC advertising is currently only legal in New Zealand and the United States, but debates are taking place worldwide as the pharmaceutical industry uses its global influence to lobby fo

APA, Harvard, Vancouver, ISO, and other styles

28

Kalokairinou, Louiza, Pascal Borry, and Heidi C. Howard. "‘It’s much more grey than black and white’: clinical geneticists’ views on the oversight of consumer genomics in Europe." Personalized Medicine 17, no. 2 (2020): 129–40. http://dx.doi.org/10.2217/pme-2019-0064.

Full text

Abstract:

Aim: Direct-to-consumer (DTC) genetic tests (GT) have created controversy regarding their risks and benefits. In view of recent regulatory developments, this article aims to explore the attitudes of European clinical geneticists toward the oversight of DTC GT. Materials & methods: Fifteen semi-structured interviews were performed with clinical geneticists based in ten European countries. The transcripts were thematically analysized in an iterative process. Results & conclusion: Respondents strongly supported quality standards for DTC GT equal to those applied within the healthcare sett

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Almost all physicians in Finland are against complete direct-to-consumer (DTC) advertising of prescription drugs,." Inpharma Weekly &NA;, no. 1446 (2004): 5. http://dx.doi.org/10.2165/00128413-200414460-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Matsuieva, Julia. "Direct-to-consumer advertisement as a factor influencing the pharmaceutical market: Legal and theoretical aspects of DTC the Polish case." Studenckie Prace Prawnicze, Administratywistyczne i Ekonomiczne 29 (September 30, 2019): 215–25. http://dx.doi.org/10.19195/1733-5779.29.15.

Full text

Abstract:

In the following paper a brief review of the current government regulations on the Polish pharmaceutical market will be provided. The Polish pharmaceutical market has its own features and peculiarities. This is the only market in the European Union where advertising of pharmacies is prohibited. Since January 1, 2012, by Article 94a of the Pharmaceutical Law Act issued May 12, 2011, it is forbidden to advertise pharmacies, pharmacy points, and their activities in Poland. In such a situation the role of direct-to-consumer advertising increases. The purpose of this study is to describe the existi

APA, Harvard, Vancouver, ISO, and other styles

31

Vares, Tiina, Annie Potts, Nicola Gavey, and Victoria M. Grace. "Hard Sell, Soft Sell: Men Read Viagra Ads." Media International Australia 108, no. 1 (2003): 101–14. http://dx.doi.org/10.1177/1329878x0310800111.

Full text

Abstract:

Viagra (known generically as sildenafil citrate) was released in New Zealand in 1998. Direct-to-consumer (DTC) advertisements represented Viagra as a panacea for men's sexual difficulties. The Research Medicines Industry Association of New Zealand (2000) claims that the Viagra DTC campaign removed the stigma associated with erectile dysfunction. However, in this paper we analyse participants' views that the advertisements also transform cultural anxieties in ways that proliferate ‘performance’ (and other) anxieties in new forms and for increasingly broad groups of people. This paper draws on m

APA, Harvard, Vancouver, ISO, and other styles

32

Park, Jin Seong, and Ho-Young (Anthony) Ahn. "Direct-to-Consumer (DTC) Antidepressant Advertising and Consumer Misperceptions About the Chemical Imbalance Theory of Depression: The Moderating Role of Skepticism." Health Marketing Quarterly 30, no. 4 (2013): 362–78. http://dx.doi.org/10.1080/07359683.2013.847337.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Vigilante, William J., and Michael S. Wogalter. "Direct-to-Consumer (DTC) Advertising of Prescription Medications on the World Wide Web: Assessing the Communication of Risks." Proceedings of the Human Factors and Ergonomics Society Annual Meeting 45, no. 17 (2001): 1279–83. http://dx.doi.org/10.1177/154193120104501705.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Poe, Pamela Zubow. "Direct-to-Consumer Drug Advertising and “Health Media Filters”: A Qualitative Study of Older Adult Women's Responses to DTC Ads." Atlantic Journal of Communication 20, no. 3 (2012): 185–99. http://dx.doi.org/10.1080/15456870.2012.692236.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Choi, Sejung Marina, and Wei-Na Lee. "Understanding the Impact of Direct-to-Consumer (DTC) Pharmaceutical Advertising on Patient-Physician Interactions: Adding the Web to the Mix." Journal of Advertising 36, no. 3 (2007): 137–49. http://dx.doi.org/10.2753/joa0091-3367360311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Jiang, Pingjun. "Asking a doctor versus referring to the Internet: A comparison study on consumers’ reactions to DTC (direct-to-consumer) prescription drug advertising." Health Marketing Quarterly 35, no. 3 (2018): 209–26. http://dx.doi.org/10.1080/07359683.2018.1514735.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Rehne, Joakim, and Claus Møldrup. "Danes' awareness of and attitude towards direct-to-consumer advertising (DTC-A) of prescription drugs: A quantitative survey of 3,000 respondents." Journal of Medical Marketing 8, no. 1 (2008): 31–38. http://dx.doi.org/10.1057/palgrave.jmm.5050120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

AHN, HO-YOUNG ANTHONY, JIN SEONG PARK, and ERIC HALEY. "Consumers' Optimism Bias and Responses to Risk Disclosures in Direct-to-Consumer (DTC) Prescription Drug Advertising: The Moderating Role of Subjective Health Literacy." Journal of Consumer Affairs 48, no. 1 (2014): 175–94. http://dx.doi.org/10.1111/joca.12028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

DeLorme, Denise E., Jisu Huh, and Leonard N. Reid. "Perceived Effects of Direct-to-Consumer (DTC) Prescription Drug Advertising on Self and Others: A Third-Person Effect Study of Older Consumers." Journal of Advertising 35, no. 3 (2006): 47–65. http://dx.doi.org/10.2753/joa0091-3367350304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Snyder, Jeremy, and Leigh Turner. "Crowdfunding for stem cell-based interventions to treat neurologic diseases and injuries." Neurology 93, no. 6 (2019): 252–58. http://dx.doi.org/10.1212/wnl.0000000000007838.

Full text

Abstract:

ObjectiveTo characterize the marketplace for direct-to-consumer (DTC) unproven stem cell-based interventions (SCBI) for neurologic diseases and injuries using crowdfunding data.MethodsSearch terms were developed from previous empirical studies of DTC businesses and the International Classification of Diseases–11 for neurologic diseases and used to query GoFundMe's internal search engine. Campaigns initiated November 2017–2018 and seeking SCBI for neurologic diseases and injuries (n = 1,030) were reviewed to identify the number of donors, number of Facebook shares, recipient location, funding p

APA, Harvard, Vancouver, ISO, and other styles

41

Saurabh, B. Gade* Mr. Dnyaneshwar S. Vyavhare Dr. Megha T. Salve. "Exploring Sales and Marketing Strategies in the Pharmaceutical Industry: A Comprehensive Review." International Journal in Pharmaceutical Sciences 1, no. 11 (2023): 192–202. https://doi.org/10.5281/zenodo.10087660.

Full text

Abstract:

The pharmaceutical industry is characterized by its complex and competitive nature, where successful sales and marketing strategies play a pivotal role in ensuring the accessibility of innovative drugs to healthcare professionals and patients. This comprehensive review article provides a detailed exploration of the multifaceted landscape of sales and marketing within the pharmaceutical sector. These strategies are critical in establishing strong relationships with healthcare professionals and institutions, delivering essential product information, and adapting to a digital-centric era. In the

APA, Harvard, Vancouver, ISO, and other styles

42

&NA;. "Direct-to-consumer (DTC) advertising of rofecoxib [Vioxx] and celecoxib [Celebrex] increased the number of patients with osteoarthritis (OA) seen by physicians each month,." Inpharma Weekly &NA;, no. 1571 (2007): 4. http://dx.doi.org/10.2165/00128413-200715710-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Kumar,, Utkarsh, Sandeep Kumar, ,Arun Kr Mahajan, Puneet Largotra, and Afzal Ansari. "Leveraging Digital Innovation to Enhance Consumer Engagement and Sales Performance in the FMCG Sector." INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 09, no. 04 (2025): 1–9. https://doi.org/10.55041/ijsrem43390.

Full text

Abstract:

The fast-moving consumer goods (FMCG) industry is a highly competitive arena, and for a brand to engage with consumers and boost their sales performance, they need to constantly innovate. This paper investigates the role of digital revolution (AI, big data analytics, social media marketing, e- commerce) in improving customer engagement and driving sales in the Fast- Moving Consumer Goods (FMCG) sector. Data-Driven Marketing plays a pivotal role in the age of digital transformation Emerging Economies. Technologies such as recommendation engines, predictive analytics, and chatbots are at the for

APA, Harvard, Vancouver, ISO, and other styles

44

Dr. Keval Govardhan Ukey , Dr. Kavita Lalchandani. "The Rise of D2C Brands Transforming India’s Consumer Market through Strategic Business Models and Navigating Legal Challenges." Cuestiones de Fisioterapia 54, no. 4 (2025): 5605–12. https://doi.org/10.48047/3aenwn68.

Full text

Abstract:

The rapid rise of Direct-to-Consumer (D2C) brands in India, while reshaping the consumerlandscape, also presents several challenges. As D2C businesses bypass traditional intermediaries, they mustnavigate complex legal and regulatory frameworks, including compliance with the Consumer Protection Act,data privacy laws under the Information Technology Act, and Goods and Services Tax (GST) regulations.Additionally, issues such as protecting intellectual property, ensuring transparent advertising practices, andmanaging customer grievances in a digital environment further complicate the business land

APA, Harvard, Vancouver, ISO, and other styles

45

Hosahally, Shashank, Madan Bharadwaj, Arkadiusz Zaremba, and Olena Volkova. "Measuring digital advertising in a post-cookie era: A study of marketing-mix models, attribution and incrementality." Journal of Digital & Social Media Marketing 12, no. 4 (2025): 348. https://doi.org/10.69554/wsat6359.

Full text

Abstract:

The implementation of the EU General Data Protection Regulation (GDPR) poses significant challenges to the measurement of advertisement performance, necessitating a shift away from traditional tracking methods such as web beacons, cookies and browser fingerprinting. With the discontinuation of thirdparty cookies and increased privacy standards, it has become harder for marketers to optimise advertising spend and attribution models. This paper explores the GDPR’s impact on the ad tech industry and anticipates challenges in adapting to a cookieless and more regulated data environment. In the wak

APA, Harvard, Vancouver, ISO, and other styles

46

Fosu, Ignatius. "Direct to Consumer (DTC) pharmaceutical advertising recall: The role of involvement." Southwestern Mass Communication Journal 32, no. 1 (2019). http://dx.doi.org/10.58997/smc.v32i1.26.

Full text

Abstract:

The effect of different amounts of risk information in DTC ads on recall was examined in an experiment. Three versions of DTC ads, containing different amounts of risk information were developed based on FDA guidelines and shown to participants in a 3 x 3 between group design. Participants’ unaided recall of ad information suggest a main effect of ad version on recall, with the ads that have moderate amount of risk information eliciting the most recall of risk information. The moderating role of involvement was inconclusive. Since the Food and Drug Administration (FDA) eased restrictions on Di

APA, Harvard, Vancouver, ISO, and other styles

47

"Impact of Direct-to-Consumer (DTC) Pharmaceutical Advertising on Patient Behavior." International Journal for Research in Management & Pharmacy 10, no. 2 (2021): 1–9. https://doi.org/10.63345/ijrmp.v10.i2.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Sassano, M., I. Hoxhaj, J. Stojanovic, A. Acampora, and S. Boccia. "Survey of Public Health Professionals on perspectives towards Direct-to-Consumer Genetic Tests." European Journal of Public Health 31, Supplement_3 (2021). http://dx.doi.org/10.1093/eurpub/ckab165.294.

Full text

Abstract:

Abstract Background The diffusion of Direct-to-Consumer Genetic Tests (DTC-GTs) requires properly literate professionals to appropriately address the challenges they pose to Public Health (PH). Hence, we conducted a survey to assess the current state of knowledge, attitudes, and behaviors of PH professionals members of the European Public Health Association (EUPHA) towards DTC-GTs. Methods The results of a scoping review conducted on PubMed to identify articles on healthcare professionals' perspectives towards DTC-GTs were used to elaborate a survey, which was validated through a focus group w

APA, Harvard, Vancouver, ISO, and other styles

49

Baroncini, Anna, Olga Calabrese, Marco Colotto, Elisabetta Pelo, Francesca Torricelli, and Stefania Boccia. "Knowledge and attitude of general pratictioners towards direct-to-consumer genomic tests: a survey conducted in Italy." Epidemiology, Biostatistics, and Public Health 12, no. 4 (2022). http://dx.doi.org/10.2427/11613.

Full text

Abstract:

 Background: Personal genomic tests (PGT) offered directly-to-consumers (DTC) for complex disease risk assessment have raised several concerns regarding their potential adverse impact. To mitigate worries continuing professional education has been advocated and the central gatekeeper role of family physicians has been highlighted. Nevertheless, to date, only few studies have been published on awareness, involvement and attitudes of primary healthcare providers on DTC marketing of PGT and, to the best of our knowledge, none in Italy. Methods: An exploratory survey to achieve informa

APA, Harvard, Vancouver, ISO, and other styles

50

Walker, Tara. "On Shaky Ground: Stigma and Otherness in Direct-to-Consumer Advertising for Bipolar Disorder Drug Treatments." Journal of Communication Inquiry, November 27, 2023. http://dx.doi.org/10.1177/01968599231215689.

Full text

Abstract:

Along with rising diagnoses for bipolar spectrum disorders, direct-to-consumer (DTC) advertisements for bipolar disorder treatments have increased in recent years. This study textually analyzes 25 ads from the brands Vraylar, Caplyta, and Latuda based on the theory and method of Hall, and supported by the work of Goffman and Thoits on stigma. Findings show that ads embodied the ambivalence associated with the spectacle of the other. Additionally, ads largely ignored the stigma of bipolar disorder, placing emphasis on the “in-between” phase where protagonists receive treatment. This emphasis on

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!